Introducing the WelchAllyn RetinaVue
February 11, 2018
Now you can easily and accurately screen for diabetic retinopathy using a SIMPLE and EFFECTIVE four-step process right at the point-of-care. The WelchAllyn RetinaVue Network is designed for healthcare providers who want to improve management of their patients with diabetes.
- Acquire - Acquire non-mydriatic fundus images in minutes with the simple, automated Welch Allyn RetinaVue 100 Imager
- Transfer - Encrypted images sent via secure HIPAA-compliant RetinaVue Network
- Analyze - Images are evaluated by a board-certified retinal specialist
- Report - Diagnostic report and referral/screening plan returned the same day —usually in 90 minutes
Patient compliance rates can double in 12 months!
For more information, click here. Or contact your Account Representative for a demo!